FDA Approves Pfizer's LITFULO™ (Ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata
LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12
Source: marketscreener.com
Page 4 - Retrospective Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Retrospective Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Retrospective Study Today - Breaking & Trending Today
Octapharma Puts a Spotlight on the Infection Burden in Patients With Chronic Lymphocytic Leukaemia (CLL) at the European Hematology Association (EHA) Hybrid Congress 2023
Real-world data and expert perspectives on state-of-the-art clinical practice for the management of infection in patients with CLL will be showcased during the Octapharma Update-in-Hematology session
Source: finanznachrichten.de
Specific Inflammatory Markers Linked to Psoriasis Area and Severity Scores
New research found that certain systemic markers in psoriatic arthritis and psoriasis patients correlated with PASI scores, indicating the clinical relevance of platelets and neutrophils in inflammation.
Source: hcplive.com
Antitrust Alarmists Get It Wrong
New research shows predictions of dire consequences to consumers when companies merge often fall flat.
Source: uschamber.com